Your Web Site
Cenix BioScience Signs Research Agreement with Regulus Therapeutics for miRNA-Targeted Drug...
News source: Business Wire Cenix BioScience GmbH (Dresden), a leading specialist in advanced RNA interference (RNAi)-based research services today announced that they have signed a research agreement with Regulus Therapeutics...

